Electroacupuncture Attenuates Cerebral Ischemia-Reperfusion Injury in Diabetic Mice Through Adiponectin Receptor 1-Mediated Phosphorylation of GSK-3β

Molecular Neurobiology

Volumn 51, Issue 2, 2015, Pages 685-695

  Guo, Fan ^a   Jiang, Tao ^a   Song, Wenying ^a   Wei, Haidong ^a   Wang, Feng ^a   Liu, Lixin ^b   Ma, Lei ^a   Yin, Hong ^a   Wang, Qiang ^a   Xiong, Lize ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

Adiponectin; Adiponectin receptor; Diabetes; Electroacupuncture; Glycogen synthesis kinase 3 beta; Ischemia reperfusion injury

Indexed keywords

ADIPONECTIN RECEPTOR; ADIPONECTIN RECEPTOR 1, MOUSE; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA;

ANIMAL; BRAIN ISCHEMIA; C57BL MOUSE; DIABETES MELLITUS, EXPERIMENTAL; ELECTROACUPUNCTURE; MALE; METABOLISM; MOUSE; PHOSPHORYLATION; PHYSIOLOGY; PROCEDURES; REPERFUSION INJURY;

ANIMALS; BRAIN ISCHEMIA; DIABETES MELLITUS, EXPERIMENTAL; ELECTROACUPUNCTURE; GLYCOGEN SYNTHASE KINASE 3; MALE; MICE; MICE, INBRED C57BL; PHOSPHORYLATION; RECEPTORS, ADIPONECTIN; REPERFUSION INJURY;

EID: 84937212625     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-014-8765-y     Document Type: Article

References (51)

1. Danaei G, Finucane MM, Lu Y, Singh GM, Cowan MJ, Paciorek CJ, Lin JK, Farzadfar F, Khang YH, Stevens GA, Rao M, Ali MK, Riley LM, Robinson CA, Ezzati M (2011) National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet 378(9785):31–40
2. Yang W, Lu J, Weng J, Jia W, Ji L, Xiao J, Shan Z, Liu J, Tian H, Ji Q, Zhu D, Ge J, Lin L, Chen L, Guo X, Zhao Z, Li Q, Zhou Z, Shan G, He J (2010) Prevalence of diabetes among men and women in China. N Engl J Med 362(12):1090–1101. doi:10.1056/NEJMoa0908292
3. Luitse MJ, Biessels GJ, Rutten GE, Kappelle LJ (2012) Diabetes, hyperglycaemia, and acute ischaemic stroke. Lancet Neurol 11(3):261–271. doi:10.1016/S1474-4422(12)70005-4
4. Sarwar N, Gao P, Seshasai SR, Gobin R, Kaptoge S, Di Angelantonio E, Ingelsson E, Lawlor DA, Selvin E, Stampfer M, Stehouwer CD, Lewington S, Pennells L, Thompson A, Sattar N, White IR, Ray KK, Danesh J (2010) Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet 375(9733):2215–2222. doi:10.1016/S0140-6736(10)60484-9
5. Bejot Y, Giroud M (2010) Stroke in diabetic patients. Diabetes Metab 36(Suppl 3):S84–S87. doi:10.1016/S1262-3636(10)70472-9
6. Kersten JR, Toller WG, Gross ER, Pagel PS, Warltier DC (2000) Diabetes abolishes ischemic preconditioning: role of glucose, insulin, and osmolality. Am J Physiol Heart Circ Physiol 278(4):H1218–H1224
7. Monteiro P, Goncalves L, Providencia LA (2005) Diabetes and cardiovascular disease: the road to cardioprotection. Heart 91(12):1621–1625. doi:10.1136/hrt.2005.063008
8. Scherer PE, Williams S, Fogliano M, Baldini G, Lodish HF (1995) A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 270(45):26746–26749
9. Ahima RS (2006) Metabolic actions of adipocyte hormones: focus on adiponectin. Obesity (Silver Spring) 14(Suppl 1):9S–15S. doi:10.1038/oby.2006.276
10. Thundyil J, Tang SC, Okun E, Shah K, Karamyan VT, Li YI, Woodruff TM, Taylor SM, Jo DG, Mattson MP, Arumugam TV (2010) Evidence that adiponectin receptor 1 activation exacerbates ischemic neuronal death. Exp Transl Stroke Med 2(1):15. doi:10.1186/2040-7378-2-15
11. Ma Y, Liu Y, Liu S, Qu Y, Wang R, Xia C, Pei H, Lian K, Yin T, Lu X, Sun L, Yang L, Cao Y, Lau WB, Gao E, Wang H, Tao L (2011) Dynamic alteration of adiponectin/adiponectin receptor expression and its impact on myocardial ischemia/reperfusion in type 1 diabetic mice. Am J Physiol Endocrinol Metab 301(3):E447–E455. doi:10.1152/ajpendo.00687.2010
12. Cohen P, Goedert M (2004) GSK3 inhibitors: development and therapeutic potential. Nat Rev Drug Discov 3(6):479–487. doi:10.1038/nrd1415
13. Dash PK, Johnson D, Clark J, Orsi SA, Zhang M, Zhao J, Grill RJ, Moore AN, Pati S (2011) Involvement of the glycogen synthase kinase-3 signaling pathway in TBI pathology and neurocognitive outcome. PLoS One 6(9):e24648. doi:10.1371/journal.pone.0024648
14. Simao F, Matte A, Pagnussat AS, Netto CA, Salbego CG (2012) Resveratrol prevents CA1 neurons against ischemic injury by parallel modulation of both GSK-3beta and CREB through PI3-K/Akt pathways. Eur J Neurosci 36(7):2899–2905. doi:10.1111/j.1460-9568.2012.08229.x
15. Collino M, Thiemermann C, Mastrocola R, Gallicchio M, Benetti E, Miglio G, Castiglia S, Danni O, Murch O, Dianzani C, Aragno M, Fantozzi R (2008) Treatment with the glycogen synthase kinase-3beta inhibitor, TDZD-8, affects transient cerebral ischemia/reperfusion injury in the rat hippocampus. Shock 30(3):299–307. doi:10.1097/SHK.0b013e318164e762
16. Eldar-Finkelman H, Ilouz R (2003) Challenges and opportunities with glycogen synthase kinase-3 inhibitors for insulin resistance and type 2 diabetes treatment. Expert Opin Investig Drugs 12(9):1511–1519. doi:10.1517/13543784.12.9.1511
17. Gross ER, Hsu AK, Gross GJ (2007) Diabetes abolishes morphine-induced cardioprotection via multiple pathways upstream of glycogen synthase kinase-3beta. Diabetes 56(1):127–136. doi:10.2337/db06-0907
18. Wang F, Tian DR, Han JS (2008) Electroacupuncture in the treatment of obesity. Neurochem Res 33(10):2023–2027. doi:10.1007/s11064-008-9822-6
19. Lee S, Kim JH, Shin KM, Kim JE, Kim TH, Kang KW, Lee M, Jung SY, Shin MS, Kim AR, Park HJ, Hong KE, Choi SM (2013) Electroacupuncture to treat painful diabetic neuropathy: study protocol for a three-armed, randomized, controlled pilot trial. Trials 14:225. doi:10.1186/1745-6215-14-225
20. Xiong L, Lu Z, Hou L, Zheng H, Zhu Z, Wang Q, Chen S (2003) Pretreatment with repeated electroacupuncture attenuates transient focal cerebral ischemic injury in rats. Chin Med J (Engl) 116(1):108–111
21. Wang Q, Peng Y, Chen S, Gou X, Hu B, Du J, Lu Y, Xiong L (2009) Pretreatment with electroacupuncture induces rapid tolerance to focal cerebral ischemia through regulation of endocannabinoid system. Stroke 40(6):2157–2164. doi:10.1161/STROKEAHA.108.541490
22. Wei H, Yao X, Yang L, Wang S, Guo F, Zhou H, Marsicano G, Wang Q, Xiong L (2013) Glycogen synthase kinase-3beta is involved in electroacupuncture pretreatment via the cannabinoid CB1 receptor in ischemic stroke. Mol Neurobiol. doi:10.1007/s12035-013-8524-5
23. Tominaga A, Ishizaki N, Naruse Y, Kitakoji H, Yamamura Y (2011) Repeated application of low-frequency electroacupuncture improves high-fructose diet-induced insulin resistance in rats. Acupunct Med J Bri Med Acupunct Soc 29(4):276–283. doi:10.1136/acupmed-2011-010006
24. Wang JK, Yu LN, Zhang FJ, Yang MJ, Yu J, Yan M, Chen G (2010) Postconditioning with sevoflurane protects against focal cerebral ischemia and reperfusion injury via PI3K/Akt pathway. Brain Res 1357:142–151. doi:10.1016/j.brainres.2010.08.009
25. Ramirez SH, Fan S, Zhang M, Papugani A, Reichenbach N, Dykstra H, Mercer AJ, Tuma RF, Persidsky Y (2010) Inhibition of glycogen synthase kinase 3beta (GSK3beta) decreases inflammatory responses in brain endothelial cells. Am J Pathol 176(2):881–892. doi:10.2353/ajpath.2010.090671
26. Hata R, Mies G, Wiessner C, Fritze K, Hesselbarth D, Brinker G, Hossmann KA (1998) A reproducible model of middle cerebral artery occlusion in mice: hemodynamic, biochemical, and magnetic resonance imaging. J Cereb Blood Flow Metab 18(4):367–375. doi:10.1097/00004647-199804000-00004
27. Tatlisumak T, Takano K, Carano RA, Miller LP, Foster AC, Fisher M (1998) Delayed treatment with an adenosine kinase inhibitor, GP683, attenuates infarct size in rats with temporary middle cerebral artery occlusion. Stroke 29(9):1952–1958
28. Wang Q, Gou X, Xiong L, Jin W, Chen S, Hou L, Xu L (2008) Trans-activator of transcription-mediated delivery of NEP1-40 protein into brain has a neuroprotective effect against focal cerebral ischemic injury via inhibition of neuronal apoptosis. Anesthesiology 108(6):1071–1080. doi:10.1097/ALN.0b013e318173f66b
29. Margolin A, Kleber HD, Avants SK, Konefal J, Gawin F, Stark E, Sorensen J, Midkiff E, Wells E, Jackson TR, Bullock M, Culliton PD, Boles S, Vaughan R (2002) Acupuncture for the treatment of cocaine addiction: a randomized controlled trial. JAMA 287(1):55–63
30. Witt C, Brinkhaus B, Jena S, Linde K, Streng A, Wagenpfeil S, Hummelsberger J, Walther HU, Melchart D, Willich SN (2005) Acupuncture in patients with osteoarthritis of the knee: a randomised trial. Lancet 366(9480):136–143. doi:10.1016/S0140-6736(05)66871-7
31. Shen J, Wenger N, Glaspy J, Hays RD, Albert PS, Choi C, Shekelle PG (2000) Electroacupuncture for control of myeloablative chemotherapy-induced emesis: a randomized controlled trial. JAMA 284(21):2755–2761
32. Wang Q, Xiong L, Chen S, Liu Y, Zhu X (2005) Rapid tolerance to focal cerebral ischemia in rats is induced by preconditioning with electroacupuncture: window of protection and the role of adenosine. Neurosci Lett 381(1–2):158–162. doi:10.1016/j.neulet.2005.02.019
33. Steffens S, Mach F (2008) Adiponectin and adaptive immunity: linking the bridge from obesity to atherogenesis. Circ Res 102(2):140–142. doi:10.1161/CIRCRESAHA.107.170274
34. Kos K, Harte AL, da Silva NF, Tonchev A, Chaldakov G, James S, Snead DR, Hoggart B, O’Hare JP, McTernan PG, Kumar S (2007) Adiponectin and resistin in human cerebrospinal fluid and expression of adiponectin receptors in the human hypothalamus. J Clin Endocrinol Metab 92(3):1129–1136. doi:10.1210/jc.2006-1841
35. Kadowaki T, Yamauchi T (2005) Adiponectin and adiponectin receptors. Endocr Rev 26(3):439–451. doi:10.1210/er.2005-0005
36. Yamauchi T, Kamon J, Ito Y, Tsuchida A, Yokomizo T, Kita S, Sugiyama T, Miyagishi M, Hara K, Tsunoda M, Murakami K, Ohteki T, Uchida S, Takekawa S, Waki H, Tsuno NH, Shibata Y, Terauchi Y, Froguel P, Tobe K, Koyasu S, Taira K, Kitamura T, Shimizu T, Nagai R, Kadowaki T (2003) Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 423(6941):762–769. doi:10.1038/nature01705
37. Guillod-Maximin E, Roy AF, Vacher CM, Aubourg A, Bailleux V, Lorsignol A, Penicaud L, Parquet M, Taouis M (2009) Adiponectin receptors are expressed in hypothalamus and colocalized with proopiomelanocortin and neuropeptide Y in rodent arcuate neurons. J Endocrinol 200(1):93–105. doi:10.1677/JOE-08-0348
38. Nishimura M, Izumiya Y, Higuchi A, Shibata R, Qiu J, Kudo C, Shin HK, Moskowitz MA, Ouchi N (2008) Adiponectin prevents cerebral ischemic injury through endothelial nitric oxide synthase dependent mechanisms. Circulation 117(2):216–223. doi:10.1161/CIRCULATIONAHA.107.725044
39. Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, Yamashita S, Noda M, Kita S, Ueki K, Eto K, Akanuma Y, Froguel P, Foufelle F, Ferre P, Carling D, Kimura S, Nagai R, Kahn BB, Kadowaki T (2002) Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 8(11):1288–1295. doi:10.1038/nm788
40. Shibata R, Sato K, Pimentel DR, Takemura Y, Kihara S, Ohashi K, Funahashi T, Ouchi N, Walsh K (2005) Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2-dependent mechanisms. Nat Med 11(10):1096–1103. doi:10.1038/nm1295
41. Yu L, Liao Y, Wu H, Zhao J, Wu L, Shi Y, Fang J (2013) Effects of electroacupuncture and Chinese kidney-nourishing medicine on polycystic ovary syndrome in obese patients. J Tradit Chin Med 33(3):287–293
42. Cline GW, Johnson K, Regittnig W, Perret P, Tozzo E, Xiao L, Damico C, Shulman GI (2002) Effects of a novel glycogen synthase kinase-3 inhibitor on insulin-stimulated glucose metabolism in Zucker diabetic fatty (fa/fa) rats. Diabetes 51(10):2903–2910
43. Collino M, Aragno M, Castiglia S, Tomasinelli C, Thiemermann C, Boccuzzi G, Fantozzi R (2009) Insulin reduces cerebral ischemia/reperfusion injury in the hippocampus of diabetic rats: a role for glycogen synthase kinase-3beta. Diabetes 58(1):235–242. doi:10.2337/db08-0691
44. Baird TA, Parsons MW, Barber PA, Butcher KS, Desmond PM, Tress BM, Colman PG, Jerums G, Chambers BR, Davis SM (2002) The influence of diabetes mellitus and hyperglycaemia on stroke incidence and outcome. J Clin Neurosci 9(6):618–626
45. Williams LS, Rotich J, Qi R, Fineberg N, Espay A, Bruno A, Fineberg SE, Tierney WR (2002) Effects of admission hyperglycemia on mortality and costs in acute ischemic stroke. Neurology 59(1):67–71
46. Jorgensen HS, Nakayama H, Raaschou HO, Olsen TS (1994) Effect of blood pressure and diabetes on stroke in progression. Lancet 344(8916):156–159
47. Remuzzi G, Schieppati A, Ruggenenti P (2002) Clinical practice. Nephropathy in patients with type 2 diabetes. N Engl J Med 346(15):1145–1151. doi:10.1056/NEJMcp011773
48. Scheen AJ (2010) Central nervous system: a conductor orchestrating metabolic regulations harmed by both hyperglycaemia and hypoglycaemia. Diabetes Metab 36(Suppl 3):S31–S38. doi:10.1016/S1262-3636(10)70464-X
49. Prioritizing interventions to improve rates of thrombolysis for ischemic stroke (2005). Neurology 64 (4):654-659. 10.1212/01.WNL.0000151850.39648.51
50. Despres JP, Golay A, Sjostrom L (2005) Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia. N Engl J Med 353(20):2121–2134. doi:10.1056/NEJMoa044537
51. Bensaid M, Gary-Bobo M, Esclangon A, Maffrand JP, Le Fur G, Oury-Donat F, Soubrie P (2003) The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells. Mol Pharmacol 63(4):908–914